Core Insights - Ceribell has achieved FedRAMP High authorization, allowing its EEG technology to be deployed in federal healthcare facilities, including U.S. Department of Veterans Affairs hospitals, enhancing rapid diagnosis for patients at risk of non-convulsive seizures [1][4][5] Group 1: Company Achievements - Ceribell is one of only 51 companies in the U.S. to receive FedRAMP High authorization, a significant cybersecurity credential that indicates compliance with the highest federal security standards [1][6] - The company's EEG system is already operational in VA hospitals following its Authority to Operate (ATO) in 2024, and the new authorization facilitates broader implementation across federal healthcare agencies [2][4] Group 2: Technology and Innovation - The Ceribell System is designed for rapid setup and continuous brain monitoring, combining portable hardware with AI-powered algorithms for quick diagnosis and ongoing patient monitoring [9] - The system is FDA-cleared for indicating suspected seizure activity and is currently utilized in intensive care units and emergency rooms across the U.S. [9] Group 3: Security and Compliance - FedRAMP High authorization reflects Ceribell's commitment to information security, ensuring that sensitive patient data is protected through rigorous security measures [5][7] - Less than 15% of FedRAMP Authorized systems meet the High security standard, highlighting the significance of Ceribell's achievement in this area [6]
Ceribell Receives FedRAMP® High Authorization, Expanding Approval for Its AI-Powered Point-of-Care EEG Across Federal Healthcare Systems